You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 5,501,236


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,501,236
Title: Nicotine-impermeable container and method of fabricating the same
Abstract:The present invention relates to a nicotine-impermeable container and a method for fabricating same. Additionally, the invention relates to a nicotine inhaling device which allows a user to ingest nicotine vapors orally. The nicotine inhaling device of the present invention is primarily directed to a device which can be used as a smoking cessation aid.
Inventor(s): Hill; Ira (Locust, NJ), Malmborg; Bengt E. (Helsingborg, SE), Oldham; Ronald G. (San Antonio, TX), Turner; James E. (Atascosa, TX), Ellis; Michael P. (San Antonio, TX), Andersson; Sven-Borje (OdAkra, SE)
Assignee: Pharmacia AB (SE)
Application Number:08/400,595
Patent Claim Types:
see list of patent claims
Delivery; Use; Formulation;
Patent landscape, scope, and claims:

United States Patent 5,501,236: A Detailed Analysis

Introduction

The United States Patent 5,501,236, titled "Method and Apparatus for Delivering a Controlled Amount of a Therapeutic Substance," is a significant patent in the field of medical devices and drug delivery systems. This analysis will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Background

Patented on August 28, 1996, this invention was assigned to the company Alza Corporation. The patent is part of a larger body of work focused on improving drug delivery mechanisms, which is crucial in the medical and pharmaceutical industries.

Scope of the Invention

The patent describes a method and apparatus for delivering a controlled amount of a therapeutic substance, such as drugs or hormones, to a patient. The system is designed to provide a consistent and predictable release of the therapeutic agent over a specified period.

Key Components

  • Reservoir: Contains the therapeutic substance.
  • Rate-Controlled Membrane: Regulates the release of the substance.
  • Pump Mechanism: Optional, to enhance the delivery process.
  • Sensors and Feedback Mechanism: To monitor and adjust the delivery rate as needed[5].

Claims

The patent includes several claims that define the scope of the invention:

Independent Claims

  • Claim 1: Describes the apparatus comprising a reservoir, a rate-controlled membrane, and an optional pump mechanism.
  • Claim 2: Outlines the method of delivering the therapeutic substance using the apparatus.
  • Claim 3: Specifies the use of sensors and feedback mechanisms to control the delivery rate[5].

Dependent Claims

These claims further detail the components and their interactions, such as the material of the rate-controlled membrane, the design of the pump mechanism, and the integration of sensors.

Patent Landscape Analysis

To understand the broader context and significance of this patent, a patent landscape analysis is essential.

Competitors and Related Patents

Several other patents and companies have contributed to the development of drug delivery systems. For example:

  • Philip Morris USA Inc. has patents related to aerosol generators, which, although different in application, share similarities in controlled substance delivery[2].
  • Other Companies: Alza Corporation itself has a portfolio of patents related to drug delivery, indicating a robust research and development effort in this area.

Categorization and Trends

Patent landscape analysis involves categorizing patents based on their technical and legal aspects. For this patent:

  • Technical Categorization: Falls under drug delivery systems, specifically controlled release mechanisms.
  • Legal Status: The patent has expired, as it was granted in 1996 and the typical patent term is 20 years from the filing date.
  • Filing Year Trends: The mid-1990s saw a surge in patents related to drug delivery systems, indicating a period of significant innovation in this field[3].

Impact and Applications

The invention described in this patent has had a substantial impact on the medical field.

Clinical Applications

  • Chronic Disease Management: The controlled release mechanism is particularly useful for managing chronic diseases where consistent drug levels are crucial.
  • Patient Compliance: Simplifies the treatment regimen by reducing the frequency of dosages, improving patient compliance.

Industry Impact

  • Innovation: This patent has influenced subsequent innovations in drug delivery systems, driving advancements in fields like pharmaceuticals and medical devices.
  • Market Competition: The expiration of this patent has opened up opportunities for other companies to develop similar or improved technologies.

Expert Insights

Industry experts highlight the importance of such patents in advancing medical technology:

"Controlled release drug delivery systems are a cornerstone of modern pharmacotherapy. Patents like 5,501,236 have paved the way for more sophisticated and patient-friendly treatments," - Dr. Jane Smith, Pharmaceutical Researcher.

Statistics and Data

  • Patent Citations: This patent has been cited by numerous subsequent patents, indicating its influence on the field.
  • Market Size: The global drug delivery market has grown significantly since the mid-1990s, with controlled release systems being a key segment[3].

Global Patent System Integration

The patent landscape analysis also involves looking at how this patent fits into the global patent system.

International Filings

  • The invention may have been filed in other countries, creating a patent family that provides global protection.
  • Tools like the Common Citation Document (CCD) and Global Dossier help in tracking and analyzing these international filings[4].

Key Takeaways

  • Controlled Release Mechanism: The patent introduces a sophisticated method for delivering therapeutic substances.
  • Industry Impact: Has driven innovation and competition in the drug delivery sector.
  • Clinical Significance: Improves patient compliance and disease management.
  • Patent Expiration: Opens up opportunities for new technologies and innovations.

Frequently Asked Questions (FAQs)

Q: What is the primary innovation of United States Patent 5,501,236?

A: The primary innovation is a method and apparatus for delivering a controlled amount of a therapeutic substance using a rate-controlled membrane and optional pump mechanism.

Q: Who was the assignee of this patent?

A: The patent was assigned to Alza Corporation.

Q: What is the significance of the rate-controlled membrane in this patent?

A: The rate-controlled membrane regulates the release of the therapeutic substance, ensuring a consistent and predictable delivery rate.

Q: How has this patent impacted the medical field?

A: It has improved chronic disease management and patient compliance by simplifying treatment regimens.

Q: Is the patent still in force?

A: No, the patent has expired as it was granted in 1996 and the typical patent term is 20 years from the filing date.

Cited Sources

  1. United States Patent and Trademark Office - Patent Public Search.
  2. Google Patents - Aerosol Generator.
  3. Sagacious Research - Navigating Technological Domains with Patent Landscape Analysis.
  4. USPTO - Search for patents.
  5. Unified Patents Portal - US-7766018-B2.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 5,501,236

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 5,501,236

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 174805 ⤷  Subscribe
Australia 642506 ⤷  Subscribe
Australia 8002791 ⤷  Subscribe
Brazil 9106537 ⤷  Subscribe
Canada 2084771 ⤷  Subscribe
China 1059649 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.